NCT01334632

Brief Summary

Brachial plexus injury after shoulder surgery with continuous interscalene block is 2.4% at 1 month and 0% at 6 months, but may be higher with a systematic postoperative neurological examination. Indeed, femoral neuropathy after anterior cruciate ligament reconstruction is 24% at 6 weeks in a cohort of 20 consecutive patients systematically screened with an electromyogram. Brachial plexus injury may be the consequence of the surgery (direct lesion by traction) or the continuous interscalene block. The goal of this study is to define the etiology of this postoperative neuropathy.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 13, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

March 20, 2014

Status Verified

April 1, 2011

Enrollment Period

1.9 years

First QC Date

April 11, 2011

Last Update Submit

March 19, 2014

Conditions

Keywords

Electrophysiological studyNerve blockAnalgesia, patient-controlledShoulder surgery

Outcome Measures

Primary Outcomes (1)

  • Incidence of brachial plexus injury

    Clinical neurological exam (diminished or absent bicipital, tricipital reflex, or sensory loss on electromyoneurogram (axon loss ratio, Hoffmann reflex, compound muscle action potentials, any fibrillation potentials of the muscle at rest) at 6 weeks. A control will be done at 3 months, 6 months and 9 months if a neuropathy is diagnosed.

    6 weeks

Study Arms (2)

Continuous interscalene block

ACTIVE COMPARATOR

Continuous interscalene block with bolus ropivacaine 0.5% and then continuous infusion of ropivacaine 0.2% 4 - 6 ml/h, associated with paracetamol and ibuprofen. Each group will contain 60 patients.

Procedure: Continuous interscalene block

PCA morphine

PLACEBO COMPARATOR

Patients with iv self-administration of morphine, associated with paracetamol and ibuprofen. Each group will contain 60 patients.

Procedure: PCA morphine

Interventions

The continuous interscalene block will be performed with ultrasound 30 minutes before the intervention.

Continuous interscalene block
PCA morphinePROCEDURE

Postoperative with iv self-administration of morphine

PCA morphine

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients planned for rotator cuff repair
  • ASA 1, 2 and 3
  • age 16 years and more

You may not qualify if:

  • peripheral neuropathy
  • pre-existing brachial plexus injury
  • diabetes mellitus
  • alcoholism
  • drug addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne

Lausanne, Canton of Vaud, 1011, Switzerland

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eric Albrecht, MD

    Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 11, 2011

First Posted

April 13, 2011

Study Start

April 1, 2011

Primary Completion

March 1, 2013

Study Completion

November 1, 2013

Last Updated

March 20, 2014

Record last verified: 2011-04

Locations